Phase I trial to assess the effects of RQ 00000010 in healthy volunteers.

Trial Profile

Phase I trial to assess the effects of RQ 00000010 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jun 2013

At a glance

  • Drugs RQ 00000010 (Primary)
  • Indications Constipation; Dyspepsia; Gastrointestinal disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Jun 2013 Positive top-line results reported in a RaQualia media release.
    • 05 Jun 2013 The summary of the clinical trial report has been submitted to the MHRA, according to a RaQualia media release.
    • 06 Nov 2012 Full results will reported in the first quarter of 2013, according to a RaQualia Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top